Selected article for: "advanced cancer and metastatic disease"

Author: Pilco Teran, Melissa; Merino Ribas, Ana; Martin Alemany, Nadia; Barros Freiria, Xoana; Rubio Casadevall, Jordi; Pérez Bueno, Ferran; García Méndez, Isabel; Castillo Devia, Marcela; Noboa Paez, Cristina; Torguet Escuder, Pere; Calabia Martínez, Jordi
Title: Acute tubulointerstitial nephritis induced by the tyrosine kinase inhibitor vandetanib.
  • Cord-id: nxjshb1t
  • Document date: 2020_7_9
  • ID: nxjshb1t
    Snippet: Few cases of immunoallergic tubulointerstitial nephritis associated with tyrosine kinase inhibitors have been described. We describe the first report case associated with vandetanib, a tyrosine kinase inhibitor indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (CMT) in patients with locally advanced or metastatic non-resectable disease.
    Document: Few cases of immunoallergic tubulointerstitial nephritis associated with tyrosine kinase inhibitors have been described. We describe the first report case associated with vandetanib, a tyrosine kinase inhibitor indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (CMT) in patients with locally advanced or metastatic non-resectable disease.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date